Dr. Sam SetarehMD, MS, FACC
Cardiology
at Beverly Hills Cardiovascular & Longevity Institute — Beverly Hills, CA
About
Sam Setareh, MD, MS, FACC earned his undergraduate degree with honors from UCLA before completing a Master of Science in Global Medicine at the Keck School of Medicine of USC. He earned his medical degree from Sackler School of Medicine, then trained in internal medicine at Mount Sinai School of Medicine in New York City. His cardiology fellowship followed at Mount Sinai Heart, Icahn School of Medicine at Mount Sinai Morningside. He holds board certification in cardiovascular disease from ABIM and fellowship standing in the American College of Cardiology.
Dr. Setareh serves as Director of Cardiovascular Performance and Prevention at Beverly Hills Cardiovascular and as a Senior Clinical Researcher at the National Heart Institute. He holds international recognition for his work in quantified plaque analysis, cardiovascular performance optimization, and AI-enhanced cardiac imaging. He has presented at the American Heart Association, the American College of Cardiology, and the European Society of Cardiology in Barcelona. His clinical interests include early atherosclerosis, Lp(a), ApoB testing, VO2 max, and GLP-1 cardiovascular benefits. Los Angeles Magazine and Super Doctors Southern California have both named him a Top Doctor. He serves on the Forbes Health Advisory Board and appeared in TIME discussing cardiovascular biomarkers and long-term health outcomes.
Education & Training
Undergraduate
University of California, Los Angeles (with Honors)
Medical School
Sackler School of Medicine
Residency
Internal Medicine, Mount Sinai School of Medicine, New York City
Fellowship
Cardiology, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai Morningside
Additional Training
MS in Global Medicine, Keck School of Medicine of USC
Certifications
Conditions Treated
Who is Dr. Setareh right for?
Dr. Setareh is an excellent fit for adults who want proactive cardiovascular risk management before symptoms appear. Patients with elevated Lp(a), ApoB, or early atherosclerosis benefit from his precision-driven approach. Executives seeking comprehensive cardiac performance evaluations will find his focus on VO2 max and advanced biomarkers directly relevant. He also serves patients curious about GLP-1 therapies and their cardiovascular implications.
Similar Doctors Nearby
Dr. Carlos QuesadaMD, MPH
Coronary artery disease, Structural heart disease, Valvular heart disease +4 more
Dr. David FilsoofMD
cardiovascular disease, heart disease, hypertension +4 more
Dr. Thomas PeroMD
testosterone deficiency, low sex drive, fatigue +5 more
Frequently Asked Questions
Dr. Setareh specializes in preventive cardiology, cardiovascular performance optimization, and executive health. He focuses on detecting early atherosclerosis and applying AI-enhanced cardiac imaging to quantify coronary plaque. His clinical interests also include Lp(a) and ApoB testing, VO2 max assessment, and the cardiovascular benefits of GLP-1 therapies.
Yes. Dr. Setareh holds board certification in cardiovascular disease from the American Board of Internal Medicine. He also holds fellowship standing in the American College of Cardiology as an FACC.
Dr. Setareh completed his internal medicine residency at Mount Sinai School of Medicine in New York City. He then trained at Mount Sinai Heart, Icahn School of Medicine at Mount Sinai Morningside for his cardiology fellowship. He also earned a Master of Science in Global Medicine from the Keck School of Medicine of USC.
Dr. Setareh serves as Director of Cardiovascular Performance and Prevention at Beverly Hills Cardiovascular & Longevity Institute. He also holds a position as Senior Clinical Researcher at the National Heart Institute.
Yes. Los Angeles Magazine and Super Doctors Southern California have both named Dr. Setareh a Top Doctor. He serves on the Forbes Health Advisory Board and appeared in TIME to discuss cardiovascular biomarkers and long-term health outcomes. He has also presented research at major cardiology conferences including the American Heart Association and the European Society of Cardiology.
Dr. Setareh uses AI-enhanced cardiac imaging to detect and quantify coronary plaque at early biological stages. His imaging work includes coronary CT angiography with AI-powered plaque analysis. He has earned international recognition for his research in this area.
Yes. Dr. Setareh takes a strong interest in cardiovascular performance optimization and longevity medicine. He uses tools such as VO2 max testing and advanced biomarker panels to assess cardiovascular fitness and long-term risk. His approach suits patients who want to optimize health, not just manage disease.
Doctor profile last updated March 21, 2026